Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Robert K. who wrote (5239)	1/4/1998 9:37:00 AM
From: Robert K.	Respond to of 17367

Well actually with a 1650 trauma trial, its gonna be expensive, but someone will help us here. I dont think we are gonna foot this whole bill ourselves. I was shopping for some alternate investments for future purchase, and I noticed that many many biotechs have liscenced their pipelines products early and cheaply. We have not. Also on the yahoo board, someone "astutely" reiterated the fact we have over 250 million of NOL's to use or lose. That will/may come in very handy.